trinity: rova-t for relapsed sclc
Published 6 years ago • 217 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
1:24
dr. pietanza on rova-t for small-cell lung cancer
-
1:56
rovalpituzumab in small cell lung cancer (sclc)
-
4:45
rova-t: first ‘targeted’ treatment for small cell lung cancer shows promise
-
1:51
dr. bauer on rovalpituzumab tesirine in sclc
-
2:52
immunotherapy treatments for small cell lung cancer (sclc)
-
2:24
the dll3-targeting bite, tarlatamab, for the treatment of sclc
-
7:14
safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (sclc)
-
1:19
what are my options for treatment and management of small cell lung cancer (sclc)?
-
1:20:51
nccn patient webinar: small cell lung cancer
-
4:55
ovarian function suppression for breast cancer: lupron or zoladex- monthly or every 3 months?
-
20:26
3mensio ct pre-case planning: redo-tavr with prior sapien 3 (2 of 2)
-
0:42
hpn328, a tri-specific t-cell engager, in sclc and neuroendocrine cancers
-
0:57
thora: high dose radiotherapy in sclc
-
0:56
next steps for the convert trial in ls-sclc
-
2:21
emerging frontline strategies in es-sclc
-
4:43
first in-human trials of rovalpituzumab for sclc
-
56:45
dr. triparna sen: small cell lung cancer research
-
1:02
evaluating the role of systemic therapies in sclc
-
1:15
dll3, a new biomarker for neuroendocrine tumors of the lung
-
3:27
new hope for cancer treatment - 3d-based position control in radiotherapy
-
8:26
dareon™-9: dll-3 bite topotecan in small cell lung cancer (sclc) • dr. aman chauhan
-
13:57
triumvira immunologics